🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this trial is to find out if a tablet called apixaban can reduce...
Status
Not Yet Recruiting
Location
University of Birmingham
Start Date
2026-03-02
Trial ID
NCT07160686
The purpose of this study is to learn whether apixaban prevents the develop...
Status
Completed
Location
Local Institution
Start Date
2007-06
Trial ID
NCT00452530
Treatments Being Tested
The primary purpose of Part 1 in this study is to assess the safety and tol...
Status
Completed
Location
Arizona Research Center
Start Date
2017-11-13
Trial ID
NCT03251482
Liver disease is the only common cause of death that is increasing in numbe...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT07726693
Treatments Being Tested
The APIXABAN-PK trial is a prospective, randomized, single-blind, placebo-c...
Status
Recruiting
Location
Asian Institute of Medical Sciences
Start Date
2026-04-01
Trial ID
NCT07521332
Treatments Being Tested
The purpose of this study is to determine if Apixaban is safer than a Vitam...
Status
Completed
Location
Cardiovascular Associates of the Southeast, LLC
Start Date
2015-06-04
Trial ID
NCT02415400
Treatments Being Tested
A single centre, double-blind, randomized, parallel group, placebo-controll...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2021-10-29
Trial ID
NCT05152420
Treatments Being Tested
The purpose of this study is to evaluate if milvexian is at least as effect...
Status
Active Not Recruiting
Location
Advanced Cardiovascular, LLC
Start Date
2023-04-11
Trial ID
NCT05757869
Treatments Being Tested
Researchers are looking for a better way to treat people with atrial fibril...
Status
Terminated
Location
SEC Clinical Research
Start Date
2022-12-05
Trial ID
NCT05643573
Treatments Being Tested
A single centre, double-blind, randomized, placebo-controlled single dose s...
Status
Active Not Recruiting
Location
ICON
Start Date
2024-02-21
Trial ID
NCT06372483